Please login to the form below

Not currently logged in
Email:
Password:

Lyell Immunopharma

This page shows the latest Lyell Immunopharma news and features for those working in and with pharma, biotech and healthcare.

GSK pays $50m upfront to tap Immatics’ cell therapy platform

GSK pays $50m upfront to tap Immatics’ cell therapy platform

Last year, it signed a five-year collaboration with Lyell Immunopharma that is also aimed at the development of cell therapies for solid tumours. ... Lyell’s technology will be used to improve GSK’s cell therapy candidates, including GSK3377794,

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....